Moderna has announced that the first trial participants have been dosed in the Phase 1/2 study of the company’s influenza vaccine candidates. The Cambridge-based biotech is applying its mRNA …
The Cambridge-based biotech giant that created one of the earliest and most effective COVID-19 vaccines is now looking to develop a flu shot.
This Phase 1/2 randomized study will evaluate the safety and immune response of a single dose of mRNA-1020 or mRNA-1030 in healthy adults 18-plus in the U.S. The company intends to enroll about 560 participants in the study.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
As war enters bloody new phase, Ukraine again calls for more weaponsAs battles tilt toward full-scale military confrontation on open terrain, Ukrainian officials are again calling for Western alliances to step up weapons supplies to help the country strengthen its position on the battlefield.
続きを読む »
EXPLAINER: Where do US opioid trials, settlements stand?A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia.
続きを読む »
A new cancer immunotherapy is substantially enhanced by mRNA vaccine technologyA novel early-stage clinical trial has shown promise for a possible cancer treatment that combines immunotherapy and an mRNA vaccine.
続きを読む »
New Jersey Approves 7 Facilities For Recreational Marijuana SalesNew Jersey regulators on Monday gave a green light to seven facilities that already sell medical marijuana to also sell recreational cannabis, although it’s not clear exactly when sales would begin.
続きを読む »
Days before start of Oakland murder trial, one defendant takes a plea, then takes the standWilliam Hommert, 26, is charged with murdering 24-year-old Lance Barr in an October 2020 shooting.
続きを読む »
CPP customers question adjustment charge as lawsuit loomsSteven Vecker of Cleveland has been dealing with major questions about the energy adjustment charge on his Cleveland Public Power monthly bill for years.
続きを読む »